Rendering

Component: (Network and Table)
Network
2409404 - Disclosure - Income Taxes - Reconciliation of U.S. Statutory Rate and Effective Tax Rate (Details)
(http://www.aeriepharma.com/role/IncomeTaxesReconciliationOfUSStatutoryRateAndEffectiveTaxRateDetails)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001337553 (http://www.sec.gov/CIK)
Income Tax Disclosure [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Income Tax Disclosure [Abstract]
 
 
 
U.S. federal tax rate (in percentage)
35.00%  
35.00%  
35.00%  
State income taxes, net of federal benefit (in percentage)
5.34%  
(0.90%) 
6.13%  
Taxable gain resulting from 2015 IP Assignment (in percentage)
0.00%  
(75.31%) 
0.00%  
Non-taxable foreign loss (in percentage)
(2.69%) 
(6.98%) 
0.00%  
Tax deferral from 2015 IP Assignment (in percentage)
(0.19%) 
3.56%  
0.00%  
Other (in percentage)
(1.45%) 
0.02%  
(0.04%) 
Valuation allowance (in percentage)
(36.20%) 
44.42%  
(41.09%) 
Effective tax rate (in percentage)
(0.19%) 
 
(0.19%) 
 
0.00%